Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Intervalo de año de publicación
1.
Nitric Oxide ; 148: 1-12, 2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38636582

RESUMEN

Epidemiological studies show a strong correlation between diabetes and the increased risk of developing different cancers, including melanoma. In the present study, we investigated the impact of a streptozotocin (STZ)-induced hyperglycemic environment on B16F10-Nex2 murine melanoma development. Hyperglycemic male C57Bl/6 mice showed increased subcutaneous tumor development, partially inhibited by metformin. Tumors showed increased infiltrating macrophages, and augmented IL-10 and nitric oxide (NO) concentrations. In vivo neutralization of IL-10, NO synthase inhibition, and depletion of macrophages reduced tumor development. STZ-treated TLR4 KO animals showed delayed tumor development; the transfer of hyperglycemic C57Bl/6 macrophages to TLR4 KO reversed this effect. Increased concentrations of IL-10 present in tumor homogenates of hyperglycemic mice induced a higher number of pre-angiogenic structures in vitro, and B16F10-Nex2 cells incubated with different glucose concentrations in vitro produced increased levels of IL-10. In summary, our findings show that a hyperglycemic environment stimulates murine melanoma B16F10-Nex2 primary tumor growth, and this effect is dependent on tumor cell stimulation, increased numbers of macrophages, and augmented IL-10 and NO concentrations. These findings show the involvement of tumor cells and other components of the tumor microenvironment in the development of subcutaneous melanoma under hyperglycemic conditions, defining novel targets for melanoma control in diabetic patients.


Asunto(s)
Hiperglucemia , Interleucina-10 , Macrófagos , Melanoma Experimental , Ratones Endogámicos C57BL , Óxido Nítrico , Animales , Interleucina-10/metabolismo , Óxido Nítrico/metabolismo , Masculino , Hiperglucemia/metabolismo , Melanoma Experimental/metabolismo , Melanoma Experimental/patología , Macrófagos/metabolismo , Macrófagos/efectos de los fármacos , Ratones , Ratones Noqueados , Línea Celular Tumoral
2.
Mucosal Immunol ; 17(2): 226-237, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38331095

RESUMEN

Invariant Natural Killer T (iNKT) cells are unconventional T cells that respond to microbe-derived glycolipid antigens. iNKT cells exert fast innate effector functions that regulate immune responses in a variety of contexts, including during infection, cancer, or inflammation. The roles these unconventional T cells play in intestinal inflammation remain poorly defined and vary based on the disease model and species. Our previous work suggested that the gut microbiota influenced iNKT cell functions during dextran sulfate sodium-induced colitis in mice. This study, shows that iNKT cell homeostasis and response following activation are altered in germ-free mice. Using prenatal fecal transplant in specific pathogen-free mice, we show that the transcriptional signatures of iNKT cells at steady state and following αGC-mediated activation in vivo are modulated by the microbiota. Our data suggest that iNKT cells sense the microbiota at homeostasis independently of their T cell receptors. Finally, iNKT cell transcriptional signatures are different in male and female mice. Collectively, our findings suggest that sex and the intestinal microbiota are important factors that regulate iNKT cell homeostasis and responses. A deeper understanding of microbiota-iNKT cell interactions and the impact of sex could improve the development of iNKT cell-based immunotherapies.


Asunto(s)
Colitis , Microbioma Gastrointestinal , Células T Asesinas Naturales , Masculino , Femenino , Ratones , Animales , Antígenos , Inflamación , Activación de Linfocitos
3.
Trends Immunol ; 43(7): 503-512, 2022 07.
Artículo en Inglés | MEDLINE | ID: mdl-35654639

RESUMEN

Invariant natural killer T (iNKT) cells are increasingly regarded as disease biomarkers and immunotherapeutic targets. However, a greater understanding of their biology is necessary to effectively target these cells in the clinic. The discovery of iNKT1/2/17 cell effector subsets was a milestone in our understanding of iNKT cell development and function. Recent transcriptomic studies have uncovered an even greater heterogeneity and challenge our understanding of iNKT cell ontogeny and effector differentiation. We propose a refined model whereby iNKT cells differentiate through a dynamic and continuous instructive process that requires the accumulation and integration of various signals within the thymus or peripheral tissues. Within this framework, we question the existence of true iNKT2 cells and discuss the parallels between mouse and human iNKT cells.


Asunto(s)
Células T Asesinas Naturales , Animales , Diferenciación Celular , Humanos , Ratones
4.
Cancers (Basel) ; 13(14)2021 Jul 16.
Artículo en Inglés | MEDLINE | ID: mdl-34298791

RESUMEN

The vast majority of studies on T cell biology in tumor immunity have focused on peptide-reactive conventional T cells that are restricted to polymorphic major histocompatibility complex molecules. However, emerging evidence indicated that unconventional T cells, including γδ T cells, natural killer T (NKT) cells and mucosal-associated invariant T (MAIT) cells are also involved in tumor immunity. Unconventional T cells span the innate-adaptive continuum and possess the unique ability to rapidly react to nonpeptide antigens via their conserved T cell receptors (TCRs) and/or to activating cytokines to orchestrate many aspects of the immune response. Since unconventional T cell lineages comprise discrete functional subsets, they can mediate both anti- and protumoral activities. Here, we review the current understanding of the functions and regulatory mechanisms of protumoral unconventional T cell subsets in the tumor environment. We also discuss the therapeutic potential of these deleterious subsets in solid cancers and why further feasibility studies are warranted.

5.
Immunohorizons ; 4(12): 797-808, 2020 12 15.
Artículo en Inglés | MEDLINE | ID: mdl-33323387

RESUMEN

CD1d-restricted invariant NKT (iNKT) cells are innate-like T cells that respond to glycolipids, a class of Ags that are invisible to conventional T cells. iNKT cells develop in the thymus where they receive strong "agonist" TCR signals. During their ontogeny, iNKT cells differentiate into discrete iNKT1, iNKT2, and iNKT17 effector subsets akin to helper CD4 T cells. In this study, we found that transgenic (Tg) expression of the canonical Vα14-Jα18 TCRα-chain at the double-positive thymocyte stage led to premature iNKT cell development and a cell-intrinsic bias toward iNKT2 cells, due to increased TCR signaling upon selection. Consistent with the strong iNKT2 bias, innate memory CD8+ T cells were found in greater numbers in Vα14 Tg mice, whereas the prevalence of mucosa-associated invariant T cells was reduced. iNKT cells from Vα14 Tg mice were hyporesponsive to stimulation by their cognate Ag α-galactosylceramide. Finally, Vα14 Tg mice displayed increased B16F10 melanoma tumor growth compared with wild-type mice. This study reveals some of the limitations of Vα14 Tg mice and warrants the cautious interpretation of past and future findings using this mouse model.


Asunto(s)
Diferenciación Celular/inmunología , Células T Asesinas Naturales/inmunología , Células T Asesinas Naturales/metabolismo , Linfocitos T Colaboradores-Inductores/inmunología , Animales , Antígenos CD1d/genética , Antígenos CD1d/metabolismo , Linfocitos T CD8-positivos/inmunología , Galactosilceramidas/farmacología , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Modelos Animales , Células T Asesinas Naturales/citología , Receptores de Antígenos de Linfocitos T/genética , Receptores de Antígenos de Linfocitos T/metabolismo , Timo/citología , Timo/inmunología , Timo/metabolismo
6.
Cell Rep ; 32(10): 108116, 2020 09 08.
Artículo en Inglés | MEDLINE | ID: mdl-32905761

RESUMEN

CD1d-restricted invariant Natural Killer T (iNKT) cells represent a unique class of T lymphocytes endowed with potent regulatory and effector immune functions. Although these functions are acquired during thymic ontogeny, the sequence of events that gives rise to discrete effector subsets remains unclear. Using an unbiased single-cell transcriptomic analysis combined with functional assays, we reveal an unappreciated diversity among thymic iNKT cells, especially among iNKT1 cells. Mathematical modeling and biological methods unravel a developmental map whereby iNKT2 cells constitute a transient branching point toward the generation of iNKT1 and iNKT17 cells, which reconciles the two previously proposed models. In addition, we identify the transcription co-factor Four-and-a-half LIM domains protein 2 (FHL2) as a critical cell-intrinsic regulator of iNKT1 specification. Thus, these data illustrate the changing transcriptional network that guides iNKT cell effector fate.


Asunto(s)
Células T Asesinas Naturales/inmunología , Análisis de la Célula Individual/métodos , Diferenciación Celular , Humanos
7.
Rev. peru. biol. (Impr.) ; 23(1): 47-52, Jan.-Apr. 2016. ilus, tab
Artículo en Español | LILACS-Express | LILACS | ID: biblio-1094245

RESUMEN

La fasciolosis es una parasitosis cosmopolita de importancia médico-veterinaria ocasionada por Fasciola hepatica, que afecta al ganado ovino, caprino y vacuno; y accidentalmente al hombre ocasionando una infección endemo-epidémica de difícil diagnóstico. El objetivo fue desarrollar un ELISA sándwich indirecto, empleando 3 anticuerpos, para identificar antígenos de secreción-excreción de Fasciola hepatica (ESFh). Para el ELISA se emplearon anticuerpos policlonales de ratón anti ESFh como anticuerpos de captura, anticuerpos policlonales de conejo anti ESFh como anticuerpos de detección, a las concentraciones de 10 y 5 μg/mL, respectivamente. Como conjugado se emplearon anticuerpos monoclonales de ratón anti-inmunoglobulinas totales de conejo ligado a peroxidasa 1/1000). Se analizaron 31 muestras de heces de ganado ovino y los resultados se compararon con los obtenidos por el examen coproparasitológico directo (CD) y contrainmunoelectroforesis (CIEF). El límite de detección obtenido para ELISA sándwich indirecto fue 100 ng/mL. La prueba presentó una sensibilidad de 100%, especificidad de 96.6% y valores predictivos positivos y negativos de 50% y 96.6% respectivamente; con relación al examen CD. Al comparar ELISA tipo sándwich indirecto con CIEF se obtuvo una especificidad de 93.5% y un valor predictivo negativo del 100%. Se concluye que la prueba de ELISA sándwich indirecto diseñada es capaz de detectar antígenos metabólicos en muestras de heces de ovino y se puede utilizar para el diagnóstico Fasciola hepatica.


Fasciolosis is a cosmopolitan parasitosis medical-veterinary importance caused by Fasciola hepatica, which affects sheep, goats and cattle; and it affects man accidentally causing an epidemic-endemic infection difficult to diagnose. The aim was to develop an indirect sandwich ELISA with 3 antibodies for detecting excretory-secretory antigens of Fasciola hepatica (ESFh). For the development of indirect sandwich ELISA were used, as capture antibody, mouse polyclonal antibodies anti ESFh and polyclonal antibodies rabbit anti-ESFh as detection antibody, at the concentrations of 10 and 5 μg/mL respectively. The conjugate used was mouse monoclonal anti- total immunoglobulins rabbit linked to peroxidase (1/1000). Were analized 31 sheep fecal samples, and the results were compared with those obtained by direct coproparasitological examination (DC) and counterimmunoelectrophoresis (CIEP). The detection limit obtained for indirect sandwich ELISA was 100 ng/mL. The test had a 100% sensitivity, 96.6% specificity, positive and negative predictive values of 50% and 96.6% respectively, in relation to DC test. Comparing with CIEP the specificity obtained for indirect sandwich ELISA was 93.5% and a negative predictive value of 100%. We concluded that indirect sandwich ELISA designed is able to detect metabolic antigens in ovine feces samples and can be used for Fasciola hepatica diagnosis.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA